{
    "Orphapacket": {
        "ORPHApacketId": "308",
        "creationDate": "2020-12-03 15:53:15",
        "version": "1.3.6 / 4.1.7 [2020-04-17] (orientdb version)",
        "copyright": "Orphanet (c) 2020",
        "ORPHAcode": "308",
        "Label": "Unverricht-Lundborg disease",
        "PURL": "http://www.orpha.net/ORDO/Orphanet_308",
        "DisorderType": {
            "value": "Malformation syndrome",
            "PURL": "http://www.orpha.net/ORDO/Orphanet_377789"
        },
        "Synonyms": [
            {
                "Synonym": "PME type 1"
            },
            {
                "Synonym": "Progressive myoclonic epilepsy type 1"
            },
            {
                "Synonym": "Progressive myoclonus epilepsy type 1"
            },
            {
                "Synonym": "ULD"
            }
        ],
        "ExternalReferences": [
            {
                "ExternalReference": {
                    "Source": "OMIM",
                    "Reference": "254800",
                    "DisorderMappingRelation": "E (Exact mapping: the two concepts are equivalent)"
                }
            },
            {
                "ExternalReference": {
                    "Source": "OMIM",
                    "Reference": "310370",
                    "DisorderMappingRelation": "BTNT (ORPHA code's Broader Term maps to a Narrower Term)"
                }
            },
            {
                "ExternalReference": {
                    "Source": "OMIM",
                    "Reference": "612437",
                    "DisorderMappingRelation": "BTNT (ORPHA code's Broader Term maps to a Narrower Term)"
                }
            }
        ],
        "TextSection": {
            "TextSectionType": "Definition",
            "Contents": "Unverricht-Lundborg disease (ULD) is a rare progressive myoclonic epilepsy disorder characterized by action- and stimulus-sensitive myoclonus and tonic-clonic seizures with ataxia but with only a mild cognitive decline over time."
        },
        "Genes": [
            {
                "Gene": {
                    "Symbol": "CSTB",
                    "Name": "cystatin B",
                    "ExternalReferences": []
                }
            },
            {
                "Gene": {
                    "Symbol": "SCARB2",
                    "Name": "scavenger receptor class B member 2",
                    "ExternalReferences": []
                }
            },
            {
                "Gene": {
                    "Symbol": "PRICKLE1",
                    "Name": "prickle planar cell polarity protein 1",
                    "ExternalReferences": []
                }
            }
        ],
        "Parents": [
            {
                "Parent": [
                    {
                        "ORPHAcode": "98261",
                        "Label": "Progressive myoclonic epilepsy"
                    }
                ]
            }
        ],
        "Phenotypes": [
            {
                "Phenotype": {
                    "HPOId": "HP:0001336",
                    "HPOTerm": "Myoclonus",
                    "HPOFrequency": "Very frequent (99-80%)"
                }
            },
            {
                "Phenotype": {
                    "HPOId": "HP:0002070",
                    "HPOTerm": "Limb ataxia",
                    "HPOFrequency": "Very frequent (99-80%)"
                }
            },
            {
                "Phenotype": {
                    "HPOId": "HP:0002392",
                    "HPOTerm": "EEG with polyspike wave complexes",
                    "HPOFrequency": "Very frequent (99-80%)"
                }
            },
            {
                "Phenotype": {
                    "HPOId": "HP:0007000",
                    "HPOTerm": "Morning myoclonic jerks",
                    "HPOFrequency": "Very frequent (99-80%)"
                }
            },
            {
                "Phenotype": {
                    "HPOId": "HP:0001251",
                    "HPOTerm": "Ataxia",
                    "HPOFrequency": "Frequent (79-30%)"
                }
            },
            {
                "Phenotype": {
                    "HPOId": "HP:0001260",
                    "HPOTerm": "Dysarthria",
                    "HPOFrequency": "Frequent (79-30%)"
                }
            },
            {
                "Phenotype": {
                    "HPOId": "HP:0002080",
                    "HPOTerm": "Intention tremor",
                    "HPOFrequency": "Frequent (79-30%)"
                }
            },
            {
                "Phenotype": {
                    "HPOId": "HP:0000726",
                    "HPOTerm": "Dementia",
                    "HPOFrequency": "Occasional (29-5%)"
                }
            },
            {
                "Phenotype": {
                    "HPOId": "HP:0000992",
                    "HPOTerm": "Cutaneous photosensitivity",
                    "HPOFrequency": "Occasional (29-5%)"
                }
            },
            {
                "Phenotype": {
                    "HPOId": "HP:0001249",
                    "HPOTerm": "Intellectual disability",
                    "HPOFrequency": "Occasional (29-5%)"
                }
            }
        ],
        "Prevalences": [
            {
                "Prevalence": {
                    "Source": "17028542[PMID]_[EXPERT]",
                    "PrevalenceType": "Point prevalence",
                    "PrevalenceQualification": "Value and class",
                    "PrevalenceClass": "1-9 / 1 000 000",
                    "ValMoy": "no data",
                    "PrevalenceGeographic": "France"
                }
            },
            {
                "Prevalence": {
                    "Source": "20301321[PMID]",
                    "PrevalenceType": "Prevalence at birth",
                    "PrevalenceQualification": "Value and class",
                    "PrevalenceClass": "1-9 / 100 000",
                    "ValMoy": "no data",
                    "PrevalenceGeographic": "Finland"
                }
            },
            {
                "Prevalence": {
                    "Source": "20301321[PMID]",
                    "PrevalenceType": "Point prevalence",
                    "PrevalenceQualification": "Value and class",
                    "PrevalenceClass": "1-9 / 100 000",
                    "ValMoy": "no data",
                    "PrevalenceGeographic": "Finland"
                }
            },
            {
                "Prevalence": {
                    "Source": "ORPHANET",
                    "PrevalenceType": "Point prevalence",
                    "PrevalenceQualification": "Class only",
                    "PrevalenceClass": "1-9 / 1 000 000",
                    "ValMoy": "no data",
                    "PrevalenceGeographic": "Europe"
                }
            }
        ],
        "AverageAgeOfOnsets": [
            {
                "AverageAgeOfOnset": {
                    "value": "Adolescent"
                }
            },
            {
                "AverageAgeOfOnset": {
                    "value": "Childhood"
                }
            }
        ],
        "TypeOfInheritances": {
            "TypeOfInheritance": [
                {
                    "value": "Autosomal recessive"
                }
            ]
        }
    }
}